Investment Update
- Q1 2024 Operating Income: 17.28 billion yen, down 1% year-on-year (expected 18.78 billion yen).
- Q1 2024 Net Income: 11.67 billion yen, down 2.7% year-on-year (expected 12.86 billion yen).
- Q1 2024 Net Sales: 259.75 billion yen, up 4.6% year-on-year (expected 258.41 billion yen).
- First Half 2024 Forecast:
- Net Sales: 515.00 billion yen (expected 529.1 billion yen).
- Net Income: 26.00 billion yen.
- Operating Income: 38.00 billion yen (expected 40.55 billion yen).
- 2025 Full Year Forecast:
- Operating Income: 77.50 billion yen (expected 81.35 billion yen).
- Net Income: 52.50 billion yen (expected 54.8 billion yen).
- Net Sales: 1.05 trillion yen (expected 1.06 trillion yen).
- Dividend: 42.00 yen (expected 41.00 yen).
- Analyst Ratings:
- 10 Buy recommendations
- 5 Hold recommendations
- 0 Sell recommendations
A look at MatsukiyoCocokara Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts evaluating MatsukiyoCocokara & Co.’s long-term outlook are optimistic, as the company has received solid Smart Scores across multiple key factors. With a strong Growth score of 4, MatsukiyoCocokara is positioned well for expansion and development in the future. The company also demonstrates Resilience and Momentum with scores of 4, indicating its ability to withstand challenges and maintain positive market traction.
Although not the highest, MatsukiyoCocokara received respectable scores in Value (3) and Dividend (2), further supporting its overall positive outlook. As a company that operates drug store chains, supermarkets, and home centers, MatsukiyoCocokara & Co. has a diversified business model that could contribute to its long-term success in the retail sector.
### Summary:
MatsukiyoCocokara & Co. operates drug store chains, retailing medicines, cosmetics, health foods, beauty care products, and more. Additionally, the company runs supermarkets and home centers, showcasing a diverse range of products and services in its portfolio. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
